Epsilon EPSN Q1 2026 In Line Whats Next for Investors Forum FRMM Q1 2026 Results Miss Estimates EPS 358 vs 022 Is ApexTreasury APXT Undervalued at 1001 20260515 Verizon Communications VZ Q1 2026 Earnings Beat Revenue NA EPS 128 Morrisons Announces Plans to Close 100 Stores Amid Rising Cost Pressures Park Medi World Could See Further Gains After 90 YTD Surge Brokerage Suggests AGX Files Lawsuit Against RR and Huntington Over Frozen Credit Line and Unpaid Carrier Invoices Anthropic and Microsoft Discuss Custom AI Chip Supply Amid 5 Billion Investment IBM Gains Over 27 Billion in Market Cap Following Trumps Quantum Computing Support Paul Tudor Jones Says No Chance Warsh Could Push Fed to Cut Rates GECCI Q1 2026 Earnings Strong EPS Beat Driven by Improved Investment Income NATR Q1 2026 Earnings Strong EPS Surprise Amid Quiet Revenue Disclosures WTI Q1 2026 Earnings Deep EPS Miss Raises Concerns EPC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Rubrik Inc RBRK Q1 2026 Earnings Strong EPS Surprise Signals Operating Leverage Teva Q1 2026 Earnings EPS Beats Estimates Stock Slips on Mixed Market Sentiment Sachem Capital Corp Notes SCCE Slips Fractionally as Bond Market Consolidates Franklin Financial Services FRAF Gains Ground Testing Key Levels After 225 Rally NioCorp Developments NB Gains 76 Approaches Key Resistance Level Fidelity D D Bancorp FDBC Edges Higher as Stock Hovers Near Key Support Zone Schneider National Inc SNDR Rises 295 as Shares Approach Key Resistance at 3610 Mediaco Holding Inc MDIA Nears Support as Shares Decline Slightly SVCO Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 274 Lowes Q1 2026 Earnings EPS Tops Estimates Amid Challenging Housing Market ODFL Q1 2026 Earnings EPS Beats Estimates Stock Rises 29 OPXS Q1 2026 Earnings Positive EPS Amid Modest Revenue Challenges ASPI Q4 2025 Earnings Significant EPS Miss Overshadowed by Strong Stock Rally AI Drug Discovery Advances May Reshape Treatment Landscape for Brain Conditions UZF Q1 2026 Earnings EPS Surges Past Estimates by 43 Moleculin Biotech MBRX Rises 327 Breaking Above Support with Resistance in Sight Jim Cramer Recommends Trimming Positions in Volatile AI Chipmaker Iran Conflict Disrupts Los Angeles Housing Market Path to Recovery Remains Uncertain RBI Rate Cut Dilutes Old Policy Framework Nomura Says Kevin Warsh Faces Five Critical Tests as New Fed Chair Small Portuguese Liqueur Brand Wins Landmark Trademark Battle Against Louis Vuitton Imunon IMNN Declines 300 Amid Market Weakness 20260513 Taylor Devices TAYD Q1 2026 Earnings Beat Revenue NA EPS 079